Cilia, hair-like organelles projecting from the surface of nearly all polarized cell types, serve essential roles in cellular signaling and motility 1 . The basic structure of motile cilia and the related organelle flagella is evolutionarily conserved. In most motile cilia, a ring of nine peripheral microtubule doublets surrounds a central pair apparatus of single microtubules that connect to the nine peripheral doublets by radial spokes (9+2 structure). Motile monocilia present at the mouse node during early embryogenesis are an exception, lacking the central pair apparatus (9+0 structure). Distinct multiprotein dynein complexes attached at regular intervals to the peripheral microtubule doublets contain molecular motors that drive and regulate ciliary motility. Specifically, ODAs are responsible for beat generation, whereas both the IDAs and the nexin link-dynein regulatory complexes (N-DRCs) regulate ciliary and flagellar beating pattern and frequency. Identifying the proteins responsible for the correct assembly of this molecular machinery is critical to understanding the causes of motile cilia-related diseases.
A r t i c l e s mucociliary airway clearance and, subsequently, chronic inflammation that regularly progresses to destructive airway disease (bronchiectasis). Organ laterality defects are also observed, with approximately half of individuals with PCD exhibiting situs inversus and, more rarely, situs ambiguus, which can associate with complex congenital heart disease 2 . Dysfunctional sperm tails (flagella) frequently cause male infertility in individuals with PCD. Another consequence of ciliary dysfunction, particularly evident in mouse models, is hydrocephalus caused by disrupted flow of cerebrospinal fluid through the cerebral aqueduct connecting the third and fourth brain ventricles 3 . Although ciliary dysmotility is not sufficient for hydrocephalus formation in humans owing to morphological differences between the mouse and human brains, the incidence of hydrocephalus, secondary to aqueduct closure, is higher in individuals with PCD 3 .
Genetic analyses of individuals with PCD have identified several autosomal recessive mutations in genes encoding axonemal subunits of the ODA complexes and related components [4] [5] [6] [7] [8] [9] [10] [11] [12] . In addition, recessive mutations in CCDC39 (MIM 613798) and CCDC40 (MIM 613799) have been linked to PCD with severe tubular disorganization and defective nexin links 13, 14 . Mutations in the radial spoke head genes RSPH4A and RSPH9 as well as in HYDIN can cause intermittent or complete loss of the central-apparatus microtubules [15] [16] [17] . Two X-linked PCD variants associated with syndromic cognitive dysfunction and retinal degeneration are caused by mutations in OFD1 (MIM 311200) and RPGR (MIM 312610), respectively 18, 19 . Another functional class of proteins emerging from the identification of PCD-causing mutations are proteins involved in the cytoplasmic preassembly of both ODAs and IDAs, including those encoded by DNAAF2 (also known as KTU; MIM 612517) 20 , DNAAF1 (also known as LRRC50; MIM 613190) 21, 22 , DNAAF3 (also known as C19orf51; MIM 614566) 23 and the recently identified LRRC6 (MIM 614930) 24 .
DYX1C1 (MIM 608706) was initially identified as a candidate dyslexia gene, owing to both a single balanced translocation t(2;15)(q11;q21) coincidentally segregating with dyslexia in a family 25 and subsequent SNP association studies. Follow-up gene association studies have provided both positive [26] [27] [28] and negative [29] [30] [31] support for association with dyslexia. Molecular and cellular analyses of DYX1C1 have indicated potential functional roles with chaperonins 32, 33 and in estrogen receptor trafficking 34 and neuronal migration 35, 36 , and recent proteomic and gene expression studies have suggested a possible role in cilia 37, 38 .
RESULTS

Generation of Dyx1c1-mutant mice
To elucidate the biological functions of DYX1C1, we performed a forward genetic experiment by producing an allele of Dyx1c1 in mice in which exons 2-4 were deleted (Fig. 1a) . Homozygous mutant mice (Dyx1c1 ∆/∆ ) expressed no detectable DYX1C1 protein by immunoblot analysis of all tissues tested, including brain and lung (Fig. 1b) . Mice heterozygous for the deletion allele were viable, fertile and not noticeably different from wild-type littermates. Homozygous mutant mice were recovered after birth from heterozygous breeding pairs at a rate deviating from the expected mendelian ratio (295:570:87 for Dyx1c1 +/+ :Dyx1c1 ∆/+ :Dyx1c1 ∆/∆ , χ = 128.017, P < 0.0001) but were recovered at early embryonic times (embryonic day (E) 6.5-12) at the expected mendelian ratio (22:43:20 , χ = 0.105, P = 0.85), suggesting embryonic lethality of approximately two-thirds of homozygous mutants. Homozygous mutants that survived after birth developed severe hydrocephalus by postnatal day (P) 16 ( Fig. 1c) and died by P21, similar to what has been described for other mouse mutants with defective motile cilia 3, 39 .
In addition to hydrocephaly, postnatal homozygous mutant mice displayed laterality defects, with 59% of mutants (51/87) showing showing situs solitus (normal left-right asymmetry). Mutations that cause disruptions in left-right asymmetry in mice 40 are known to result from defects in the function of motile nodal monocilia and, more specifically, the loss of cilia-generated leftward flow across the node in early embryogenesis 40 . The typical phenotype for laterality mutants is a 1:1 ratio of situs inversus totalis and situs solitus, indicating a randomization of left-right patterning, although the inv mutant mouse has 100% of affected pups with situs inversus. Even if the ratio of situs inversus to situs solitus seen in surviving Dyx1c1-mutant mice deviates significantly from what would be expected for a 1:1 ratio of situs inversus to situs solitus (51:21, χ = 12.5, P = 0.0004), this ratio was already observed in other mutants for left-right patterning, such as in Dnahc5-mutant mice 41 . Consistent with a role for DYX1C1 function in the embryonic node where left-right patterning is established in the mouse, we found by whole-mount in situ hybridization that Dyx1c1 expression in the early embryo (E7.5) was restricted to pit cells of the embryonic node (Fig. 1e) .
In an independent mouse ENU mutagenesis screen for congenital heart defects (CHDs) of the National Heart, Lung, and Blood Institute (NHLBI) Bench to Bassinet Program, we recovered a mutant named Sharpei with a Dyx1c1 missense mutation (c.T2A) that resulted in an altered AUG start codon and expression of an aberrant N-terminally truncated DYX1C1 protein product of approximately 31 kDa (Supplementary Fig. 1a ). This mutant was recovered on the basis of having a complex CHD and was therefore carefully histologically phenotyped. Some mutants with apparent situs inversus comprising dextrocardia with inverted lung lobation and right-sided stomach also had subtle visceral organ situs defects, such as discordant leftsided pancreas and spleen, despite right-sided stomach positioning (Supplementary Fig. 1b ). Sharpei mutants with complex CHD died prenatally or at birth with a spectrum of defects, such as transposition of the great arteries with ventricular septal defect (VSD) and coronary fistula ( Supplementary Fig. 1b and Supplementary Video 1) or double-outlet right ventricle with right atrial isomerism, muscular and atrioventricular septal defects ( Supplementary Fig. 1b and Supplementary Videos 2 and 3). All these findings resemble CHDs observed in other mouse models of PCD such as Dnahc5-mutant mice 41 .
Knockdown of dyx1c1 in zebrafish
Recently, it was shown that knockdown of dyx1c1 results in phenotypes characteristically associated with cilia defects, such as body curvature, hydrocephalus, cystic kidneys and situs inversus 42 . To test whether DYX1C1 has an evolutionarily conserved role in establishing left-right asymmetry in vertebrates, we also performed morpholino-mediated knockdown experiments in zebrafish embryos. In zebrafish, dyx1c1 is expressed in embryonic tissues that contain motile cilia 42 , including Kupffer's vesicle, which is known to have an important role in establishing the left-right axis. Morpholinomediated knockdown of zebrafish dyx1c1 resulted in hydrocephalus, kidney cysts and body-axis curvature, phenotypes consistent with ciliary dysfunction in zebrafish. Morpholino-mediated knockdown of dyx1c1 also produced laterality defects (Fig. 2a,b) , as assessed by the position of the heart (cmlc2), liver (fkd2) and pancreas (ins) in dyx1c1-morphant embryos at 48 h post-fertilization (h.p.f.). In a wild-type zebrafish embryo, the ventricle of the heart loops toward the right, the atrium loops toward the left, the liver is positioned to the left of the midline and the pancreas lies to the right of the midline (Fig. 2a) . We observed this wild-type pattern in 36.5% of the morphants, whereas 37.9% of the morphants showed a complete reversal of the placement of these organs (Fig. 2b) . A heterotaxic (or situs ambiguus) phenotype was seen in 25.6% of the embryos (Fig. 2b) . To investigate when dyx1c1 affects early left-right patterning, we studied the expression of the zebrafish nodal gene southpaw (spaw) in a time course of morpholino-injected embryos. The expression of zebrafish spaw is restricted to the left lateral-plate mesoderm (LPM) during somitogenesis before asymmetric organ positioning at 48 h.p.f. (ref. 43) . At the 12-to 14-somite stage, 82.8% of the control embryos had left LPM expression of spaw, whereas all of the morphant embryos lacked any expression of spaw, indicating that spaw initiation is delayed in the absence of dyx1c1 (Fig. 2b) . The delay in spaw expression upon loss of ciliary motility in Kupffer's vesicle (Fig. 2b) . Thus, in the zebrafish embryo, dyx1c1 is necessary for the left-sided expression of spaw in the left LPM, which is a crucial step for normal left-right axis development. Overall, our results confirm previous findings 42 . Furthermore, we demonstrate that knockdown of dyx1c1 affects the left-sided expression of spaw, consistent with a key role for this factor in left-right axis development.
Analysis of ependymal cilia
Hydrocephalus and organ laterality defects are hallmarks of mutations that cause defects in ciliary motility in mice and zebrafish 1, 3 . We therefore used light and electron microscopy as well as videomicroscopy to determine whether DYX1C1 deficiency caused loss of motile cilia formation or loss of cilia. Cilia extending from mouse ependymal cells of the cerebral ventricles, visualized by light microscopy, appeared similar in length and distribution in Dyx1c1 ∆/∆ and wild-type littermates (Fig. 3a) . Although cilia were abundant on respiratory epithelial cells in mutants and wild-type mice, cilia in mutants lacked immunofluorescence signal for both the ODA heavy chain Mdnah5 and the IDA light chain Dnali1 proteins (Fig. 3b,c) . Loss of these dyneins from motile cilia would be predicted to cause a loss of motility. We used live-cell imaging to directly assess cilia-mediated fluid flow and ciliary motility on the ependymal surface in Dyx1c1 ∆/∆ mice. We prepared explants or slices of the lateral ventricular surfaces from Dyx1c1 ∆/∆ and wildtype mice at P6. Ependymal cilia in wild-type mice continued to beat vigorously in these preparations and created a directional fluid flow across the surface that could be visualized by the displacement of a small volume of India ink pressure-injected onto the ependymal surface. This flow was present in all wild-type mice tested (n = 6; Fig. 3d and Supplementary Video 4) but was completely absent in tissue obtained from all Dyx1c1 ∆/∆ mice tested (n = 4; Fig. 3d and Supplementary Video 5). We next examined the motility of ependymal cilia in coronal brain slices of wild-type and Dyx1c1 ∆/∆ mice by infrared differential interference contrast (DIC) videomicroscopy. Cilia at the ependymal surface in wild-type and heterozygous mice (n = 8) were found to beat at a frequency of approximately 9 beats/s (34 °C; Supplementary Video 6), whereas cilia on ependymal cells from all Dyx1c1 ∆/∆ examined (n = 4) lacked ciliary beating (Supplementary Video 7). Videomicroscopy of tissue slices from the third brain ventricle in newborn homozygous Sharpei mutants also showed completely immotile cilia (n = 7; Supplementary Video 8).
Beads added to the solution above the brain slice exhibited only random motion, whereas, in wild-type littermate controls, the beads showed ependymal cilia-generated flow (Supplementary Video 8) .
Similarly, videomicroscopy of the tracheal airway epithelia in newborn homozygous Sharpei mutants showed completely immotile cilia, consistent with PCD, whereas littermate controls showed normal rapid synchronous ciliary beat (Supplementary Video 9). We also assessed the motility of cilia in Kupffer's vesicle in dyx1c1-morphant zebrafish with videomicroscopy. dyx1c1 morphants had cilia in Kupffer's vesicles that lacked motility compared to the cilia in uninjected embryos (Supplementary Videos 10 and 11). 
A r t i c l e s
Analysis of Dyx1c1-mutant respiratory cilia
To assess the ultrastructure of respiratory cilia in mutants, we obtained transmission electron micrographs of tracheal cilia. As on the ependymal surface, tracheal cilia were abundant in both wild-type and Dyx1c1 ∆/∆ epithelial cells (Fig. 3e) , but, unlike tracheal cilia in wildtype mice, cilia in the Dyx1c1 ∆/∆ trachea were surrounded by cellular debris and mucus (Fig. 3e) . We further examined the ultrastructure of tracheal cilia in cross-sections by transmission electron microscopy (TEM). Using TEM, we observed that tracheal cilia in wild-type and mutant mice had typical 9+2 microtubular structure with intact radial spokes (Fig. 3f) . In contrast and consistent with the absence of heavy and light chain dynein subunits (Fig. 3b) , cilia in Dyx1c1 ∆/∆ mice lacked both ODA and IDA structures in respiratory cilia (Fig. 3f) . Thus, the phenotype caused by loss of function of Dyx1c1 is a severe ciliary motility defect associated with absent axonemal ODA and IDA structures.
Mutation analysis of DYX1C1 in individuals with PCD
The apparent conservation of function of DYX1C1 in mice and zebrafish prompted us to search for mutations in DYX1C1 in humans with PCD, the disorder connected with defective ciliary motility. Because of the observed ultrastructural phenotype and severe ciliary beating defect in Dyx1c1 ∆/∆ mice, we considered DYX1C1 an excellent candidate gene for PCD with abnormal axonemal ODA and IDA assembly. DYX1C1, located on chromosome 15q21.3, comprises ten exons (translation starts in exon 2) and encompasses 77.93 kb of genomic DNA. In one highly inbred Irish family (UCL-200), a copy number variation (CNV) analysis of whole-exome sequence data (using ExomeDepth) 44 identified a homozygous DYX1C1 deletion in two affected siblings (UCL-200 II:1 and UCL-200 II:2; Supplementary  Fig. 2a,b) . This finding was confirmed by Sanger sequencing of the deletion breakpoints, and the deletion was present in a heterozygous state in their carrier mother (Supplementary Fig. 2c ). The 3.5-kb deletion led to loss of exon 7 of DYX1C1 (Fig. 4a) . Notably, the same 3.5-kb deletion was also identified in individuals with PCD in five US and Australian families. Five of these individuals were heterozygous for the deletion along with a mutation in the splice donor site of exon 6, stop-gain mutations and a frameshift mutation in the other allele (UNC-158, UNC-159, UNC-1669, UNC-1839 and UNC-1171; Fig. 4a and Supplementary Fig. 3e-h) , and one individual was homozygous for the deletion (UNC-663; Supplementary Fig. 3i ). In addition, we screened all DYX1C1 exons and adjacent intronic sequences by PCR amplification and subsequent Sanger DNA sequencing in 105 individuals with PCD with combined ODA and IDA defects. Mutations were identified in ten affected individuals from nine unrelated families that predicted premature termination of translation (Fig. 4a,b and Supplementary Table 1) . In all families, the mutations segregated with disease status, consistent with an autosomal recessive inheritance pattern (Supplementary Figs. 2 and 3) . In three families, we confirmed recessively inherited homozygous mutations by sequencing other family members (F648 II1, OP-359 II1 and OP-556 II1). In another family, the affected individual, OP-86 II2, was compound heterozygous for two different mutations, with each mutation tracking uniquely to one of parent (Supplementary Fig. 3a) . We therefore identified a total of nine human DYX1C1 mutations (Supplementary Table 1 ). Apart from the 3.5-kb deletion and a splice-site mutation, the other seven mutations were predicted to cause premature protein termination and clustered toward the middle of the 420-amino-acid sequence, between amino acids 128 and 195 (Fig. 4b) . Thus, seven of the nine identified mutations are predicted to result in a truncated DYX1C1 protein that would lack more than half of the protein, including the C-terminal tetratricopeptide-repeat (TPR) domain. The TPR domains in DYX1C1 have been shown previously to be functionally important domains required for the activities of DYX1C1 in neuronal motility, its cellular localization and its interaction with molecular chaperones 33, 35 . Table 1) , and one male subject was treated for infertility, having three children by assisted reproduction, suggesting a probable function for DYX1C1 in sperm tails. Five of the 12 affected individuals had situs inversus totalis (42%), 2 had situs ambiguous (16%), 1 with dextrocardia and polysplenia and 1 with left atrial isomerism and polysplenia, and 5 had situs solitus (42%). Thus, DYX1C1 deficiency in humans causes disruption of left-right body asymmetry, similar to the findings observed in mice and zebrafish. Notably, none of these individuals were diagnosed with dyslexia or hydrocephaly. Hydrocephalus is a common phenotype in mouse mutants with immotile cilia but is rare in humans with PCD 3, 39 . Two affected individuals in this study had a learning disability, but this phenotype can probably be attributed to other causes, including microcephaly (OP-86 II2 and UCL-200 II:1).
Clinical phenotypes of individuals with DYX1C1 mutations
All 12 individuals with biallelic DYX1C1 mutations suffered from classical symptoms of PCD, including recurrent upper and lower airway disease and bronchiectasis. Seven had neonatal respiratory distress syndrome. Four exhibited reduced fertility (Supplementary
Dynein-arm defects in DYX1C1-deficient respiratory cilia
Respiratory cilia isolated from individuals with biallelic DYX1C1 mutations displayed severe ultrastructural defects (Fig. 4c-f) resembling the defects observed in mouse Dyx1c1 mutants (Fig. 3b,c,e) . Specifically, both ODA and IDA defects were present in TEM analyses in all ten probands assessed (OP-86 II2, OP-556 II1, UNC1669, UNC1839, UNC1171, UNC158, UNC159, UNC663, UCL-200 II:1 and UCL-200 II:2) (Fig. 4c and Supplementary Table 1) . To further understand the defect at the molecular level, we performed immunofluorescence microscopy of cilia using antibodies targeting components of the axonemal ODA, IDA and N-DRC. Immunofluorescence analysis showed absence of or marked reduction in the levels of the proteins normally present in type 1 and type 2 ODA complexes (DNAH5, DNAH9 and DNAI2; Fig. 4d,e and Supplementary  Figs. 4-6 ) as well as for IDA subtype complexes (DNALI1; Fig. 4f and Supplementary Fig. 7) . These findings are similar to cytoplasmic preassembly (DNAAF) defects reported in ciliary axonemes with mutant DNAAF2 (ref. 20) , DNAAF1 (refs. 21, 22) and DNAAF3 (ref. 23) . Notably, we found that the extent of axonemal ODA defects varied among the respiratory cells tested, and, in some cases, the ODA proteins DNAH5 and DNAI2 could be partially detected in the axonemes (Supplementary Figs. 4 and 6) . Assembly of proximal type 1 ODA complexes (positive and negative for DNAH9) seemed to be better preserved than distally localized type 2 ODA complexes (positive for DNAH5 and DNAH9; Supplementary Figs. 4-6) . To further understand the functional consequences of our observations, we performed nasal brush biopsies in affected individuals (F-648 II1, OP-86 II2, UNC1669, UNC1839, UNC1171, UNC663, UCL-200 II:1 and UCL-200 II:2) and analyzed respiratory cilia beating by highspeed videomicroscopy. Videomicroscopy showed that most respiratory cells had immotile cilia (Supplementary Videos 12 and 13) ; however, cilia were found to beat in some respiratory cells, albeit with reduced frequency (Supplementary Videos 14 and 15) relative to control cilia (Supplementary Video 16) . These variable motility defects in DYX1C1-mutant cells are consistent with our previous npg A r t i c l e s observations of variable degrees of axonemal ODA defects. Notably, only DNAAF2 mutations in humans have been shown to yield respiratory cells with similarly variable ODA defects and associated IDA abnormalities 20 .
Cellular sublocalization and interaction partners of DYX1C1
The phenotypes described above as well as previously reported interactions between exogenously expressed DYX1C1 protein and molecular chaperones suggested to us that DYX1C1 might function as a newly identified cytoplasmic axonemal dynein assembly factor. Consistent with this possibility, we found by immunofluorescence that mouse DYX1C1 protein was located in the cytoplasm of respiratory epithelia (Fig. 5a) . We confirmed this finding by immunoblot by showing that, similar to DNAAF2, human DYX1C1 was also present in the cytoplasmic protein fraction and was almost undetectable in the axonemal protein fraction of human respiratory cells (Fig. 5b) . Considering the similarities in phenotype caused by DYX1C1 and DNAAF2 mutations with regard to variable ODA defects, we tested for possible 
A r t i c l e s
interactions between these proteins. Using Myc-and Flag-tagged proteins that were coexpressed in HEK293 cells, we found by coimmunoprecipitation that DYX1C1 interacted with DNAAF2 ( Fig. 5c) but not with the cytoplasmic preassembly factors DNAAF1 and DNAAF3 or with the PCD-associated protein CCDC103 that is localized to both the cytoplasm and axoneme and has a role in dynein-arm attachment ( Supplementary Fig. 8 ), as well as with the newly identified dynein-arm assembly protein LRRC6 (data not shown). Furthermore, we demonstrated that DYX1C1 and DNAAF2 interacted directly by yeast two-hybrid assay (Fig. 5d) . On the basis of these findings, we hypothesize that DYX1C1 represents a new cytoplasmic axonemal dynein assembly factor, possibly acting together with DNAAF2 at an early step in cytoplasmic ODA and IDA assembly.
To categorize the molecular function of DYX1C1 more completely in respiratory tissue, we defined the protein interactome of DYX1C1 in mouse trachea by coimmunoprecipitation and tandem mass spectrometry. We prepared input extracts for coimmunoprecipitation from the trachea tissue of either wild-type or mutant mice and found that these appeared similar in protein composition, as evaluated by Coomassie staining after SDS-PAGE (Supplementary Fig. 8a ). After coimmunoprecipitation with antibodies to DYX1C1, Coomassie-stained protein bands were apparent in preparations from wild-type extracts but not in those generated from mutant extracts (Supplementary Fig. 8a ). We cut 14 matched pairs of gel pieces covering the range from approximately 20 to 200 kDa, with many pieces containing multiple bands, from wild-type and mutant coimmunoprecipitations and subjected them to tryptic digestion and tandem mass spectrometry analysis for protein identification. In all, we identified 702 proteins in immunoprecipitates from wild-type trachea and 29 proteins in gel slices from the immunoprecipitates from trachea expressing mutant protein (Supplementary Table 2 ). To determine whether the identified DYX1C1 protein interactome was enriched for particular molecular or biological functions, we used the Database for Annotation, Visualization and Integrated Discovery (DAVID) to determine the presence of enriched Panther Gene Ontology terms in the DYX1C1 interactome and proteins identified in the knockout control. Using a mouse lung proteome as background, we found several molecular functional categories enriched in the DYX1C1 interactome, and several of these were in categories containing molecular chaperones (MF00077: chaperone, P < 0.001; BP00062: protein folding, P < 0.01; BP00072: protein complex assembly, P < 0.05; and MF00078: chaperonin, P = 0.05; Supplementary Table 3 ). All four of these chaperone-containing categories were not significantly enriched in the protein set identified in the immunoprecipitates with mutant protein (Supplementary Table 3 ). The DYX1C1 interactome contained a total of 28 proteins in the chaperone or chaperonin category, including 6 of 8 subunits in the T-complex chaperonin complex and multiple heat-shock proteins. We confirmed by coimmunoprecipitation and protein blot analysis the interactions of six chaperones with DYX1C1, including Cct3, Cct4, Cct5, Cct8, Hsp70 and Hsp90 (Supplementary Fig. 8b ).
DISCUSSION
The protein interactions we found in tracheal tissue with endogenous DYX1C1 are in agreement with the results from a recent study using 45 . Our results provide the first evidence that may link the T complex of chaperones, known primarily for its role in cytoskeletal protein assembly, to the folding and assembly of axonemal dynein complexes. Notably, evidence for a role of Cct proteins in the cytoplasmic assembly of the protein complexes required for motile cilia has been reported for Tetrahymena 46 . Although the DYX1C1 mouse interactome defined with tandem mass spectrometry did not include any of the known DNAAF proteins, absence in a tandem mass spectrometry screen does not necessarily mean absence of interaction and highlights the importance of screening for potential interactors by several means. This study is the first to our knowledge to show the effects of DYX1C1 deficiency in humans, mice and zebrafish. The phenotypes in all species are consistent in showing a selective defect in motile cilia, reflecting deficient dynein-arm transport or assembly. Furthermore, because the human subjects in this study with mutations in DYX1C1 showed no evidence of dyslexia, we propose that the loss of DYX1C1 function might not be a highly penetrant cause of dyslexia. In conclusion, on the basis of the pattern of cilia defects observed, its cellular localization, a protein interactome enriched for chaperones and genetic-physical interaction with DNAAF2, we propose that DYX1C1 represents a new axonemal dynein assembly factor (DNAAF4).
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METhODS
Methods and any associated references are available in the online version of the paper. 
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ONLINE METhODS
Gene targeting and genotyping of Dyx1c1 ∆/∆ mice. Mice carrying the loxPexon 2-4-loxP conditional allele of Dyx1c1 (Dyx1c1 flox2-4 ) were generated by the University of Connecticut Health Center Gene Targeting and Transgenic Facility. Embryonic stem cells harboring a loxP-flanked allele of exons 2-4 of Dyx1c1 were produced by electroporating mouse embryonic stem (ES) cells (129S6) with a targeting construct designed to replace exons 2-4 and flanking intronic sequence through homologous recombination. We screened 96 ES cell clones by PCR for correctly targeted colonies. A single positive colony was expanded and used for embryo reaggregation to produce five chimeric mice. Three of these mice were shown to transmit the targeted allele through the germ line to offspring in a cross with C57BL/6J mice. The PGK-Neo cassette in the targeting construct was then removed by crossing these mice with 129S4/SvJaeSor-Gt(ROSA)26Sor tm1(FLP1)Dym /J mice (The Jackson Laboratory). These offspring were used to generate a colony of Dyx1c1 flox2-4/flox2-4 mice. To generate Dyx1c1 del2-4/del2-4 (Dyx1c1 ∆/∆ ) mice with a deletion of exons 2-4, we crossed Dyx1c1 flox2-4/flox2-4 mice with hypoxanthine-guanine phosphoribosyltransferase (Hprt)-cre mice, C57B6/6-Hprtt m1(cre)Mnn /J (University of Connecticut Health Center). Genotyping was subsequently performed by PCR using two pairs of primers (Fig. 1a and Supplementary Table 4) . Animal procedures were performed under protocols approved by the Institutional Animal Care and Use Committee of the University of Connecticut and conform to US NIH guidelines.
Whole-mount in situ hybridization of Dyx1c1 mouse embryos. Sense and antisense probes for Dyx1c1 were generated from a 554-bp pCRII-TOPO construct (nucleotides 1098-1651; RefSeq NM_026314.3, Mus musculus Dyx1c1 transcript variant 1) produced by TOPO TA cloning (Invitrogen) after amplification from cDNA. Probes were synthesized with digoxigenin NTPs (Roche) after template linearization with HindIII (antisense) or NotI (sense) before RNA synthesis with T7 or SP6 RNA polymerase, respectively. For wholemount in situ hybridization, staged embryos were fixed overnight at 4 °C in 4% paraformaldehyde in 1× PBS. Whole-mount in situ hybridization was then performed according to standard procedures with minor modifications 47 . Stained samples were transferred into 80% glycerol, and images were captured using a Scion CFW-1310C color digital camera mounted on an Axioskop2 plus microscope (Zeiss) and Image-Pro Express.
Immunohistochemistry of mouse tissue. Mice were perfused transcardially with 0.9% saline followed by 4% paraformaldehyde (Electron Microscopy Science) in 1× PBS. Brains were removed, fixed overnight in the same fixative at 4 °C and washed in 1× PBS three times for 40 min the next day before cutting into 50-µm sections with a vibratome (VT-1000S, Leica). Nuclei were counterstained with Hoechst 33342 (2 µg/ml in PBS; Sigma). Stained sections were washed for 10 min in PBS, coverslips were applied using Prolong Gold Antifade (Invitrogen), and images were acquired on a Carl Zeiss Axiovert 200M inverted microscope with an ApoTome attachment and Axiovision 4.6 software (Carl Zeiss). Whole mounts of the entire lateral wall of the lateral ventricles were prepared as described previously 48 , fixed overnight in 4% paraformaldehyde in PBS at 4 °C and washed in 1× PBS three times for 40 min the next day. They were then permeabilized with 0.1% Triton X-100 (Sigma) in PBS for 10 min, blocked in 10% goat serum (Invitrogen) in PBS and 0.1% Triton X-100 for 1 h, and incubated with the following primary antibodies: mouse antibody to acetylated tubulin (1:500 dilution; Sigma, T6793), rabbit antibody to β-catenin (1:100 dilution; Cell Signaling Technology, 9562) and mouse antibody to γ-tubulin (1:500 dilution; Sigma, T6557). After washing three times in PBS, tissues were incubated with appropriate Alexa Fluor dye-conjugated secondary antibodies (Goat Anti-Rabbit 488 (A11008), Goat Anti-Mouse 488 (A11001), Goat Anti-Rabbit 568 (A11011) and Goat AntiMouse 568 (A11031), Invitrogen) at a dilution of 1:400 for 1 h. Tissues were washed in PBS and incubated for 5 min in 2 µg/ml Hoechst 33342 (Sigma) for counterstaining of nuclei. Secondary antibodies alone were used as a control. Whole mounts were placed onto depressed glass slides, and cover slips with CoverWell imaging chambers (Grace Bio-Labs) were applied. Samples were imaged either on a Carl Zeiss Axiovert 200M inverted microscope with an ApoTome attachment and Axiovision 4.6 software (Carl Zeiss) or on a Leica TCS SP2 confocal laser scanning microscope.
Immunofluorescence of dissociated mouse nasal epithelial cells. Nasal epithelial cells were harvested from mouse septa by acute dissociation on a 4-well slide in 1:1 PBS/HBSS. Slides were dried to let the cells adhere to the wells, and cells were immediately fixed with 4% paraformaldehyde for 2 min at room temperature. Cells were then washed twice with 1× PBS for 2 min for each wash. Blocking buffer (10% goat serum and 0.1% Triton X-100 in 1× PBS) was added for 15 min at room temperature. Slides were incubated with rabbit polyclonal antibody to DYX1C1 (Sigma, SAB4200128) at a 1:500 dilution and mouse monoclonal antibody to acetylated tubulin (Sigma, T7451) at a 1:1,000 dilution in the same blocking buffer for 30 min at room temperature. After three washes with 1× PBS for 5 min each, slides were incubated with Alexa Fluor 488-conjugated goat antibody to rabbit (Invitrogen, A11034; 1:5,000 dilution) and Alexa Fluor 568-conjugated goat antibody to mouse (Invitrogen, A11031; 1:1,000 dilution) for 20 min at room temperature. Slides were washed twice with 1× PBS for 5 min each, and nuclear stain Hoechst 33342 (Invitrogen, H3570) at a 1:2,500 dilution was added for 15 min at room temperature. Slides were dried, and cover slips were applied with Prolong Gold Antifade (Invitrogen, P36930). Cells were imaged on a Leica TCS Sp2 laser scanning microscope.
TEM.
To collect brains, mice (12 d old) were perfused transcardially with 0.9% saline followed by 2% paraformaldehyde/2.5% glutaraldehyde in 0.1 mM phosphate buffer. Brain samples were further fixed by immersion overnight in 2% paraformaldehyde/2.5% glutaraldehyde in 0.1 mM phosphate buffer and were washed in phosphate buffer three times for 40 min per wash. Sections were postfixed with 2% OsO 4 in 0.1 mM phosphate buffer for 1.5 h and were dehydrated through a graded ethanol series. After dehydration, tissues were washed twice in acetone and embedded in epoxy resin in capped inverted Beem capsules. Thin sections were cut with a diamond knife, placed onto Formvar-coated slot grids and heavy metal stained with uranyl acetate and lead citrate. Trachea tissues were directly dissected without perfusion and were fixed by immersion overnight in 2% paraformaldehyde/2.5% glutaraldehyde in 0.12 mM phosphate buffer. They were washed in phosphate buffer three times (60 min in total), postfixed in 1% OsO 4 and 0.8% potassium ferricyanide in 0.12 M phosphate buffer for 1 h, dehydrated through a graded ethanol series, rinsed twice in acetone and embedded in epoxy resin. Thin sections were cut with a diamond knife, placed on copper grids and heavy metal stained with ethanolic uranyl acetate and Sato's lead citrate. Electron micrographs were captured using an FEI Tecnai 12 Biotwin TEM equipped with a side-mounted AMT XR-40 CCD camera and Epson Expression 1680 flatbed scanners.
Scanning electron microscopy. Wild-type and mutant mouse embryos (E7.5) were collected and fixed in 1.5% paraformaldehyde/1.5% glutaraldehyde in 0.10 M sodium cacodylate containing 0.05 M NaCl overnight at 4 °C. Samples were postfixed with 2% OsO 4 in the same buffer overnight and were dehydrated using a graded ethanol series. Specimens were dried in a Polaron E3000 Critical-Point Dryer and mounted onto aluminum specimen mounts (Ted Pella) using carbon tape and silver paint (Ernest F. Fullam). Each mount was sputter coated with gold palladium (60% gold, 40% palladium) using a Polaron E5100 Sputter Coater. Samples were examined and photographed using a LEO DSM982 field emission scanning electron microscope.
Protein blots of brain, lung and trachea lysates. Wild-type and mutant mouse brains and lungs were collected and lysed in RIPA Buffer (Sigma) supplemented with 1× Protease Inhibitor Cocktail (Sigma). For tracheal and lung preparation, tissues were dissected and carefully separated from the surrounding tissues. Samples were homogenized using a tissue homogenizer and cleared by centrifugation at 10,000g for 10 min. Proteins were separated on 10% SDS-PAGE minigels and then transferred to Immobilon (Millipore) membrane for protein blotting. For detecting DYX1C1 protein, the antibody to N-terminal DYX1C1 (Sigma, SAB4200128) was used at a dilution of 1:200; antibody to GAPDH (Sigma, G8795) was used at a 1:1,500 dilution as a loading control. LI-COR Odyssey infrared secondary antibodies (goat antibody to mouse 680 (926-32220), goat antibody to mouse 800 (926-32210) goat antibody to mouse 680 (926-32221) and goat antibody to mouse 800 (926-32211)) were used at dilutions of 1:10,000. All blots were imaged and analyzed using a LI-COR Odyssey Scanner and Software. npg Laboratory Technology) and suspended in cell culture medium. Samples were spread onto glass slides, air dried and stored at −80 °C until use. Cells were treated with 4% paraformaldehyde, 0.2% Triton X-100 and 1% skim milk before incubation with primary antibody (for 2-3 h at room temperature or overnight at 4 °C) and secondary antibody (for 25 min at room temperature). Appropriate controls were performed omitting the primary antibodies. Mouse monoclonal antibody to DNAI2 (1:200 dilution; H00064446-M01 (clone1C8)) was obtained from Abnova. Mouse monoclonal antibody to acetylated tubulin (1:10,000 dilution; T7451-200UL) and rabbit polyclonal antibody to CCDC39 (1:300 dilution; HPA035364) were obtained from Sigma. Rabbit polyclonal antibodies to DNAH5 and DNALI1 were generated as reported 58, 59 . Highly crossadsorbed secondary antibodies, including Alexa Fluor 488-conjugated goat antibody to mouse (1:1,000 dilution; A11029) and Alexa Fluor 546-conjugated goat antibody to rabbit (1:1,000 dilution; A11035), were from Molecular Probes (Invitrogen). DNA was stained with Hoechst 33342 (1:1,000 dilution; 14533-100MG, Sigma) or DAPI (1:1,000 dilution; 32670-25MG-F, Sigma). Immunofluorescence images were taken with a Zeiss Apotome Axiovert 200 microscope and processed with AxioVision 4.8 and Adobe Creative Suite 4.
cDNA cloning. The following clones were purchased from Origene: DYX1C1 (SC313387), DNAAF3 (SC126165) and CCDC103 (RC208345). cDNA clones for DNAAF2 and DNAAF1 were amplified by two-step (nested) PCR from human bronchial epithelial cell cDNA (3214, ScienCell; Supplementary Table 6) for Gateway cloning. All PCR products were amplified using KOD polymerase according to the manufacturer's directions, recombined with the pDONR201 Gateway vector via BP Clonase II reaction and subcloned into Gateway entry vectors encoding Myc and 3× Flag epitope tags via LR Clonase reaction.
Preparation of human respiratory cell lysates. Human respiratory cells were obtained either by brushing or cell culture (spheroids) 60 . Cells were incubated in 800-1,000 µl of NP-40 or RIPA lysis buffer containing protease inhibitor cocktail (P8340, Sigma-Aldrich) on ice for 30 min and were occasionally vortexed. Lysates were spun at 20,817g at 4 °C for 10 min. Supernatants were moved to a new tube (cytoplasmic fraction). Pellets were resuspended in 100-150 µl of modified Reeds high-salt extraction buffer 61 (30 mM HEPES, pH 7.4, 5 mM MgSO 4 , 0.1 mM EDTA, 625 mM NaCl, 2 mM DTT, 70 mM β-mercaptoethanol and 0.1% Triton X-100) containing protease inhibitor cocktail (P8340, Sigma-Aldrich) and incubated on ice for 30-60 min with frequent vortexing. Lysates were spun down at 20,817g at 4 °C for 10 min. Supernatants were moved to a new tube (axonemal fraction). Lysates were visualized by silver staining using the ProteoSilver silver staining kit (PROTSIL1-1KT, Sigma-Aldrich) and stored at −20 °C or −80 °C until use. Using this method, we obtained two protein fractions, the first enriched for cytoplasmic proteins (cytoplasmic fraction) and the second enriched for axonemal proteins (axonemal fraction). We confirmed enrichment of cytoplasmic proteins with antibody to DNAAF2 (Fig. 5b) and of axonemal proteins with antibody to LRRC48 (Fig. 5b) .
Coimmunoprecipititation assays of epitope-tagged constructs and protein blotting. HEK293 cells were transfected with plasmids encoding Mycand Flag-tagged proteins using Gene Juice (Novagen) with approximately 0.1 µg/ml DNA in the medium. Within 24 h, cells were collected in 1× PBS and lysed in 1 ml of buffer containing 50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1% IGEPAL, 0.5 mM EDTA and 10% glycerol supplemented with protease inhibitor cocktail (Roche Complete) and phosphatase inhibitors (Cocktails 2 and 3, Sigma-Aldrich). Lysates were centrifuged at 16,000g for 30 min at 4 °C. Approximately 2 mg of each lysate was precleared with 4 µg of rabbit control IgG for 2 h at 4 °C and was incubated with MagSi/protein A beads (MagnaMedics) for 1 h. Lysates were incubated with 4 µg of rabbit antibody to Flag or with antibody to Myc overnight at 4 °C and were then incubated with MagSi/protein A beads for 1 h to capture immunoprecipitates. Bead complexes were washed four times in lysis buffer and were resuspended in 1× LDS buffer supplemented with DTT (1/8 lysis volume) and heated for 10 min at 90 °C. Lysates were electrophoresed in NuPAGE 4-12% Bis-Tris gels, transferred to PVDF membranes and subsequently immunoblotted with mouse monoclonal antibody to either Myc (A7) or Flag (M2). PVDF
